1. Home
  2. INDI vs CSTL Comparison

INDI vs CSTL Comparison

Compare INDI & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo indie Semiconductor Inc.

INDI

indie Semiconductor Inc.

HOLD

Current Price

$3.15

Market Cap

784.1M

Sector

Technology

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$23.59

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDI
CSTL
Founded
2007
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
784.1M
806.3M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
INDI
CSTL
Price
$3.15
$23.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$6.25
$47.17
AVG Volume (30 Days)
5.9M
345.5K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
3.95
N/A
EPS
N/A
N/A
Revenue
$217,394,000.00
$344,229,000.00
Revenue This Year
$25.54
$2.42
Revenue Next Year
$38.45
$12.69
P/E Ratio
N/A
N/A
Revenue Growth
0.33
3.66
52 Week Low
$1.53
$14.59
52 Week High
$6.05
$44.28

Technical Indicators

Market Signals
Indicator
INDI
CSTL
Relative Strength Index (RSI) 54.91 25.39
Support Level $2.32 $21.77
Resistance Level $3.68 $24.46
Average True Range (ATR) 0.17 0.97
MACD 0.11 0.14
Stochastic Oscillator 77.13 1.15

Price Performance

Historical Comparison
INDI
CSTL

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: